Antimicrobial resistance (AMR) poses a major threat to global public health.1 The burden of AMR falls disproportionately upon low- and middle-income countries (LMICs), and in recent years, several ...

Professor Sir Tumani Corrah is the Emeritus Director of the Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene & Tropical Medicine (LSHTM) and founder and Co-President of ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

Despite significant advances in early detection, surgery, radiotherapy, and systemic treatment of breast cancer, late relapse ...

Countries have a legal obligation to combat climate change. The challenge for health is to make sure that they comply. Udani ...

Neutralising monoclonal antibodies (NAbs) are being developed for future respiratory virus threats, notably highly pathogenic ...

Singapore’s Healthier SG initiative, as reviewed by Foo and colleagues,1 signals a transformative shift in national healthcare strategy—centred on prevention, continuity, and patient centred care.

In September, 2025, global stakeholders will convene at the United Nations General Assembly for the fourth High-Level Meeting ...

Born in São Paulo, Brazil, to parents who were doctors, Luciana Rodrigues Silva came to Bahia State aged 2 years, and from an ...

Making a clinical diagnosis of dengue, Zika, or chikungunya is notoriously difficult. These arboviral diseases share ...

High-risk infants often require prolonged hospitalisation in the neonatal intensive care unit (NICU) during a crucial period when their brain is highly sensitive to external experiences.1 From an ...

On July 17, 2025, the US Food and Drug Administration (FDA) authorised marketing of five Juul e-cigarette products to adults, ...